Prenatal and perinatal risk factors for neuroblastoma

International Journal of Cancer

Volumn 123, Issue 12, 2008, Pages 2885-2890

  Bluhm, Elizabeth ^a,b   McNeil, Dawn Elizabeth ^c   Cnattingius, Sven ^d   Gridley, Gloria ^a   El Ghormli, Laure ^e   Fraumeni Jr , Joseph F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Anemia; Case control study; Delayed effects; Neuroblastoma; Prenatal; Prenatal exposure

Indexed keywords

ANEMIA; APGAR SCORE; ARTICLE; CANCER SURVIVAL; CHILDBIRTH; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUROBLASTOMA; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS; RISK FACTOR;

ADULT; ANEMIA; APGAR SCORE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL RECORD LINKAGE; NEUROBLASTOMA; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; REGISTRIES; RESPIRATORY INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; YOUNG ADULT;

EID: 57349133069     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23847     Document Type: Article

References (53)

1. Brodeur G, Maris J. Neuroblastoma, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2002.
2. Goodman MT, Gurney JG, Smith MA, Olshan AF. Sympathetic nervous system tumors. In: Ries LA, Smith MA, Gurney JG, et al., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, 1999. 65-72.
3. Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 2005;353:2243-53.
4. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
5. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991;63:993-9.
6. Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, Bondy ML, Pollock BH. Maternal medication use and neuroblastoma in offspring. Am J Epidemiol 2004;159:721-31.
7. Kramer S, Ward E, Meadows AT, Malone KE. Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst 1987;78:797-804.
8. Schuz J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J. Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol 2001;54:702-9.
9. Schuz J, Weihkopf T, Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr 2007;166:433-41.
10. Spitz MR, Johnson CC. Neuroblastoma and paternal occupation. A case-control analysis. Am J Epidemiol 1985;121:924-9.
11. De Roos AJ, Olshan AF, Teschke K, Poole C, Savitz DA, Blatt J, Bondy ML, Pollock BH. Parental occupational exposures to chemicals and incidence of neuroblastoma in offspring. Am J Epidemiol 2001;154:106-14.
12. Hamrick SE, Olshan AF, Neglia JP, Pollock BH. Association of pregnancy history and birth characteristics with neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Paediatr Perinat Epidemiol 2001;15:328-37.
13. Urayama KY, Von Behren J, Reynolds P. Birth characteristics and risk of neuroblastoma in young children. Am J Epidemiol 2007;165:486-95.
14. Chow EJ, Friedman DL, Mueller BA. Maternal and perinatal characteristics in relation to neuroblastoma. Cancer 2007;109:983-92.
15. Johnson CC, Spitz MR. Neuroblastoma: case-control analysis of birth characteristics. J Natl Cancer Inst 1985;74:789-92.
16. Menegaux F, Olshan AF, Reitnauer PJ, Blatt J, Cohn SL. Positive association between congenital anomalies and risk of neuroblastoma. Pediatr Blood Cancer 2005;45:649-55.
17. Neglia JP, Smithson WA, Gunderson P, King FL, Singher LJ, Robison LL. Prenatal and perinatal risk factors for neuroblastoma. A case-control study. Cancer 1988;61:2202-6.
18. Foulkes WD, Buu PN, Filiatrault D, Leclerc JM, Narod SA. Excess of congenital abnormalities in French-Canadian children with neuroblastoma: a case series study from Montreal. Med Pediatr Oncol 1997;29:272-9.
19. Nakissa N, Constine LS, Rubin P, Strohl R. Birth defects in three common pediatric malignancies; Wilms' tumor, neuroblastoma and Ewing's sarcoma. Oncology 1985;42:358-63.
20. Miller RW, Fraumeni JF, Jr, Hill JA. Neuroblastoma: epidemiologic approach to its origin. Am J Dis Child 1968;115:253-61.
21. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 1996;143:996-1001.
22. Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH. Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology 2002;13:575-80.
23. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol Ther 2007;81:685-91.
24. Daniels JL, Olshan AF, Pollock BH, Shah NR, Stram DO. Breastfeeding and neuroblastoma, USA and Canada. Cancer Causes Control 2002;13:401-5.
25. Linet MS, Gridley G, Cnattingius S, Nicholson HS, Martinsson U, Glimelius B, Adami HO, Zack M. Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control 1996;7:437-48.
26. Cnattingius S, Zack M, Ekbom A, Gunnarskog J, Linet M, Adami HO. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biomarkers Prev 1995;4:441-5.
27. Cnattingius S, Zack MM, Ekbom A, Gunnarskog J, Kreuger A, Linet M, Adami HO. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 1995;87:908-14.
28. Adami J, Glimelius B, Cnattingius S, Ekbom A, Zahm SH, Linet M, Zack M. Maternal and perinatal factors associated with non-Hodgkin's lymphoma among children. Int J Cancer 1996;65:774-7.
29. Cnattingius S, Ericson A, Gunnarskog J, Kallen B. A quality study of a medical birth registry. Scand J Soc Med 1990;18:143-8.
30. Ericson A, Eriksson M, Westerholm P, Zetterstrom R. Pregnancy outcome and social indicators in Sweden. Acta Paediatr Scand 1984;73:69-74.
31. The National Board of Health and Welfare. The Swedish Medical Birth Register: a summary of content and quality. Centre for epidemiology, 2003.
32. The National Board of Health and Welfare. Cancer incidence in Sweden 1997. Stockholm, Sweden: NBHW, 1999.
33. Cancer incidence in Sweden. Centre for Epidemiology, The National Board of Health and Welfare 2004. Stockholm, Sweden: NBHW, 2006.
34. Yearly report of causes of death. 1996. Stockholm, Sweden: 1998.
35. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993;15:414-43.
36. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32:260-7.
37. Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005;81:1218S-1222S.
38. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci 2000;900:125-36.
39. Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993;329:536-41.
40. French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L, Greenberg M, Koren G. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 2003;74:288-94.
41. Buck GM, Michalek AM, Chen CJ, Nasca PC, Baptiste MS. Perinatal factors and risk of neuroblastoma. Paediatr Perinat Epidemiol 2001;15:47-53.
42. Maxwell P, Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther 2004;3:29-35.
43. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
44. Jogi A, Ora I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, Axelson H, Pahlman S. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002;99:7021-6.
45. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K, Poellinger L, Pahlman S. Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell 2006;10:413-23.
46. Schwartzbaum JA, George SL, Pratt CB, Davis B. An exploratory study of environmental and medical factors potentially related to childhood cancer. Med Pediatr Oncol 1991;19:115-21.
47. Miller RW. Childhood cancer and congenital defects. A study of US death certificates during the period 1960-1966. Pediatr Res 1969;3:389-97.
48. Mili F, Khoury MJ, Flanders WD, Greenberg RS. Risk of childhood cancer for infants with birth defects. I. A record-linkage study, Atlanta, Georgia, 1968-1988. Am J Epidemiol 1993;137:629-38.
49. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 1997;60:474-85.
50. George RE, Lipshultz SE, Lipsitz SR, Colan SD, Diller L. Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr 2004;144:444-8.
51. Yamamoto K, Ohta S, Ito E, Hayashi Y, Asami T, Mabuchi O, Higashigawa M, Tanimura M. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J Clin Oncol 2002;20:1209-14.
52. Newton HB, Ray-Chaudhury A, Cavaliere R. Brain tumor imaging and cancer management: the neuro-oncologists perspective. Top Magn Reson Imaging 2006;17:127-36.
53. Savitz DA, Hertz-Picciotto I, Poole C, Olshan AF. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev 2002;24:91-101.